Studies Paint Nuanced Picture of Insulin Out-of-Pocket Costs

Medicare enrollees this fall will be able to sign up for prescription plans that cap copayments for insulin at $35 a month. A recent Kaiser Family Foundation analysis shows that average annual out-of-pocket spending on insulin among Medicare Part D enrollees without low-income subsidies (LIS) increased from $324 in 2007 to $580 in 2017. Meanwhile, a new study in JAMA Internal Medicine found that insulin accounted for just 18% of all out-of-pocket spending among privately insured patients with type 1 diabetes in 2018 — and accounted for less out-of-pocket spending than diabetes-related supplies.

© 2022 MMIT
Jinghong Chen

Jinghong Chen Reporter

Jinghong produces infographics and data stories on health insurance and specialty pharmacy for AIS Health. She graduated from Missouri School of Journalism with a focus on data journalism and international reporting. Before joining AIS in 2018, she worked at WBEZ, Al Jazeera English and The New York Times Chinese.

Related Posts

workers-prepping-infusion-drug
May 12

Major PBMs Look Ahead to 2023 for Biosimilars Boom

READ MORE
wall-street-sign
May 12

Centene Plans to Sell Magellan Rx, PANTHERx Rare for $2.8 Billion

READ MORE
pills-and-dollars
May 12

Study: With High Prices, Rebate Revenue Is Growing for PBMs

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today